Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
<p>Cancer testis antigens (CTA) represent attractive targets for targeted radiotherapy and imaging as their expression is restricted to cancer and germ cells. NY-ESO-1, a member of the CTA family, is highly immunogenic and expressed in multiple tumor types including carcinoma of bladder, liver...
Main Author: | Chu, H |
---|---|
Other Authors: | Vallis, K |
Format: | Thesis |
Language: | English |
Published: |
2013
|
Subjects: |
Similar Items
-
Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
by: Lourenço, J
Published: (2024) -
Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells
by: Pagotto, A, et al.
Published: (2013) -
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
by: Chen, J, et al.
Published: (2015) -
Functional analysis of cancer/testis antigens in human cancer
by: Pagotto, A
Published: (2013) -
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.
by: Wadle, A, et al.
Published: (2010)